The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Adriaan A. Voors(University Medical Center Groningen), Piotr Ponikowski(Wroclaw Medical University), Róbert Gábor Kiss, Martina Brueckmann, John R. Teerlink(University of Glasgow), Michael Fu(Rutgers, The State University of New Jersey), Maurizio Volterrani(Vita-Salute San Raffaele University), Mitchell A. Psotka(Alaska Heart and Vascular Institute), Morten Schou(British Heart Foundation), Henrik Schirmer(ESCP Business School), Yasushi Sakata(Osaka University), Mikhail Kosiborod(AstraZeneca (Brazil)), Lenka Špinarová(Masaryk University), Sean P. Collins(Wayne State University), Jerzy Krzysztof Wranicz(Medical University of Lodz), Stefan Janssens(Maastricht University), Robert J. Mentz(Duke University), Jasper Tromp(Duke-NUS Medical School), Afshin Salsali(Rutgers, The State University of New Jersey), Christiane E. Angermann(Universitätsklinikum Würzburg), Jan Biegus(Wroclaw Medical University), Jon Blatchford(Boehringer Ingelheim (United Kingdom)), Shelley Zieroth(University of Manitoba), J COMINCOLET(Bellvitge University Hospital), Uwe Zeymer(University of Freiburg), Michael E. Nassif(Saint Luke's Health System), João Pedro Ferreira(Inserm), P. Christian Schulze(Temple College), C. Jan Willem Borleffs(Haga Hospital), Changsheng Ma(Second Hospital of Shandong University)
Cited by 889
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k